310 related articles for article (PubMed ID: 11991532)
21. Rapid analysis of amphetamine, methamphetamine, MDA, and MDMA in urine using solid-phase microextraction, direct on-fiber derivatization, and analysis by GC-MS.
Jurado C; Giménez MP; Soriano T; Menéndez M; Repetto M
J Anal Toxicol; 2000; 24(1):11-6. PubMed ID: 10654563
[TBL] [Abstract][Full Text] [Related]
22. Rapid simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine, 3,4-methylenedioxymethamphetamine, and 3,4-methylenedioxyethylamphetamine in urine by solid-phase extraction and GC-MS: a method optimized for high-volume laboratories.
Stout PR; Horn CK; Klette KL
J Anal Toxicol; 2002; 26(5):253-61. PubMed ID: 12166811
[TBL] [Abstract][Full Text] [Related]
23. Gas chromatographic/mass spectrometric assay for profiling the enantiomers of 3,4-methylenedioxymethamphetamine and its chiral metabolites using positive chemical ionization ion trap mass spectrometry.
de Boer D; Tan LP; Gorter P; van de Wal RM; Kettenes-van den Bosch JJ; de Bruijn EA; Maes RA
J Mass Spectrom; 1997 Nov; 32(11):1236-46. PubMed ID: 9373962
[TBL] [Abstract][Full Text] [Related]
24. Mixed-mode solid-phase extraction procedures for the determination of MDMA and metabolites in urine using LC-MS, LC-UV, or GC-NPD.
Jenkins KM; Young MS; Mallet CR; Elian AA
J Anal Toxicol; 2004; 28(1):50-8. PubMed ID: 14987425
[TBL] [Abstract][Full Text] [Related]
25. Enantiomeric separation and quantitation of (+/-)-amphetamine, (+/-)-methamphetamine, (+/-)-MDA, (+/-)-MDMA, and (+/-)-MDEA in urine specimens by GC-EI-MS after derivatization with (R)-(-)- or (S)-(+)-alpha-methoxy-alpha-(trifluoromethy)phenylacetyl chloride (MTPA).
Paul BD; Jemionek J; Lesser D; Jacobs A; Searles DA
J Anal Toxicol; 2004 Sep; 28(6):449-55. PubMed ID: 15516295
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and capillary electrophoretic analysis of enantiomerically enriched reference standards of MDMA and its main metabolites.
Pizarro N; de la Torre R; Farré M; Segura J; Llebaria A; Joglar J
Bioorg Med Chem; 2002 Apr; 10(4):1085-92. PubMed ID: 11836119
[TBL] [Abstract][Full Text] [Related]
27. Selection and optimization of hydrolysis conditions for the quantification of urinary metabolites of MDMA.
Pirnay SO; Abraham TT; Lowe RH; Huestis MA
J Anal Toxicol; 2006 Oct; 30(8):563-9. PubMed ID: 17132253
[TBL] [Abstract][Full Text] [Related]
28. Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans.
Fallon JK; Kicman AT; Henry JA; Milligan PJ; Cowan DA; Hutt AJ
Clin Chem; 1999 Jul; 45(7):1058-69. PubMed ID: 10388483
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylenedioxyamphetamine in squirrel monkey and human plasma after acidic conjugate cleavage.
Mueller M; Peters FT; Huestis MA; Ricaurte GA; Maurer HH
Forensic Sci Int; 2009 Jan; 184(1-3):64-8. PubMed ID: 19131196
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of multiple internal standards: deuterated analogues of methylenedioxymethamphetamine, methylenedioxyamphetamine, methamphetamine, and amphetamine.
Lin DL; Liu HC; Yin RM; Chen DT; Soong SJ; Liu RH
J Anal Toxicol; 2004; 28(8):650-4. PubMed ID: 15538959
[TBL] [Abstract][Full Text] [Related]
31. Optimization of enantioselective high-performance liquid chromatography-tandem mass spectrometry method for the quantitative determination of 3,4-methylenedioxy-methamphetamine (MDMA) and its phase-1 metabolites in human biological fluids.
Sprega G; Kobidze G; Lo Faro AF; Pichini S; Farkas T; Tini A; Mskhiladze A; Busardò FP; Chankvetadze B
J Pharm Biomed Anal; 2024 Jun; 243():116076. PubMed ID: 38430614
[TBL] [Abstract][Full Text] [Related]
32. Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA.
Peters FT; Samyn N; Lamers CT; Riedel WJ; Kraemer T; de Boeck G; Maurer HH
Clin Chem; 2005 Oct; 51(10):1811-22. PubMed ID: 16099938
[TBL] [Abstract][Full Text] [Related]
33. Optical isomer analysis of 3,4-methylene-dioxyamphetamine analogues and their stereoselective disposition in rats.
Matsushima K; Nagai T; Kamiyama S
J Anal Toxicol; 1998; 22(1):33-9. PubMed ID: 9491966
[TBL] [Abstract][Full Text] [Related]
34. Confirmation of amphetamine, methamphetamine, MDA and MDMA in urine samples using disk solid-phase extraction and gas chromatography-mass spectrometry after immunoassay screening.
Huang Z; Zhang S
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(2):241-7. PubMed ID: 12860031
[TBL] [Abstract][Full Text] [Related]
35. MDA-MDMA concentrations in urine specimens.
Kunsman GW; Levine B; Kuhlman JJ; Jones RL; Hughes RO; Fujiyama CI; Smith ML
J Anal Toxicol; 1996; 20(7):517-21. PubMed ID: 8934299
[TBL] [Abstract][Full Text] [Related]
36. Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS.
Peters FT; Samyn N; Wahl M; Kraemer T; De Boeck G; Maurer HH
J Anal Toxicol; 2003; 27(8):552-9. PubMed ID: 14670133
[TBL] [Abstract][Full Text] [Related]
37. Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscreen ONLINE amphetamine, and a modified Abuscreen ONLINE amphetamine screening immunoassays for the detection of amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) in human urine.
Stout PR; Klette KL; Wiegand R
J Anal Toxicol; 2003; 27(5):265-9. PubMed ID: 12908938
[TBL] [Abstract][Full Text] [Related]
38. Molecularly imprinted-solid phase extraction combined with simultaneous derivatization and dispersive liquid-liquid microextraction for selective extraction and preconcentration of methamphetamine and ecstasy from urine samples followed by gas chromatography.
Djozan D; Farajzadeh MA; Sorouraddin SM; Baheri T
J Chromatogr A; 2012 Jul; 1248():24-31. PubMed ID: 22704883
[TBL] [Abstract][Full Text] [Related]
39. Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats.
Shima N; Katagi M; Kamata H; Zaitsu K; Kamata T; Nishikawa M; Miki A; Tsuchihashi H; Sakuma T; Nemoto N
Xenobiotica; 2008 Mar; 38(3):314-24. PubMed ID: 18274959
[TBL] [Abstract][Full Text] [Related]
40. Stereoselective method development and validation for determination of concentrations of amphetamine-type stimulants and metabolites in human urine using a simultaneous extraction-chiral derivatization approach.
Wan Raihana WA; Gan SH; Tan SC
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(1):8-16. PubMed ID: 21147046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
